Literature DB >> 10341027

Aluminum-induced osteogenesis in osteopenic rats with normal renal function.

C Gómez-Alonso1, P Menéndez-Rodríguez, M J Virgós-Soriano, J L Fernández-Martín, M T Fernández-Coto, J B Cannata-Andía.   

Abstract

Previous studies have shown a different effect of aluminum (Al) on bone metabolism in animals with chronic renal failure and conversely, positive osteogenic effects in animals with normal renal function. The aim of this study was to evaluate the effect of aluminum on bone metabolism in osteopenic rats. We studied male Wistar rats with severe osteopenia induced by adding NH4Cl (2%) to the drinking water over a 6-month period. The rats were divided into two groups and followed for 4 months. The Aluminum group (G1) received AlC13 intraperitoneally (10 mg/kg/5 days/week) (n = 8); the Control group (G2) did not receive any treatment after stopping the administration of NH4Cl (n = 5). In all animals we measured biochemical markers (serum Ca, P, Cr, Al, osteocalcin, hydroxyproline) as well as bone mineral density and bone histomorphometry (BV/TV, CTh, ObS/BS, OTh, and NOc/TV). Bone aluminum content, measured by atomic absorption spectrometry, was 101.6 +/- 13 microg/g in the Al overloaded group and 1.31 +/- 0.14 in controls. Bone mineral density, evaluated by dual X-ray absorptiometry (DXA) at the proximal extremity of the tibia was significantly higher in G1 (0.292 +/- 0.01 g/cm2 versus 0. 267 +/- 0.02 g/cm2). No significant differences were found between the biochemical markers. In the histomorphometric parameters we observed significant differences in G1 compared with G2: an increase in BV/TV (18.59 +/- 5.6 versus 7.69 +/- 3.08%) and in CTh (0.52 +/- 0.06 versus 0.36 +/- 0.07 mm) with a moderate increment of the osteoid thickness (14.05 +/- 4.72 versus 5.25 +/- 0.9 microm) (P < 0. 05). Changes in others parameters and the relationship between biochemical parameters of bone remodeling, Al, and histology were analyzed. These findings indicate that in rats with normal renal function, Al is able to induce bone formation even when osteopenia is present.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10341027     DOI: 10.1007/s002239900645

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  5 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  The aluminum content of bone increases with age, but is not higher in hip fracture cases with and without dementia compared to controls.

Authors:  Hans-Olov Hellström; Bengt Mjöberg; Hans Mallmin; Karl Michaëlsson
Journal:  Osteoporos Int       Date:  2005-07-27       Impact factor: 4.507

3.  Indirect regulation of PTH by estrogens may require FGF23.

Authors:  Natalia Carrillo-López; Pablo Román-García; Ana Rodríguez-Rebollar; José Luis Fernández-Martín; Manuel Naves-Díaz; Jorge B Cannata-Andía
Journal:  J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 10.121

4.  No association between the aluminium content of trabecular bone and bone density, mass or size of the proximal femur in elderly men and women.

Authors:  Hans-Olov Hellström; Bengt Mjöberg; Hans Mallmin; Karl Michaëlsson
Journal:  BMC Musculoskelet Disord       Date:  2006-08-23       Impact factor: 2.362

Review 5.  Applications of Metals for Bone Regeneration.

Authors:  Kristina Glenske; Phil Donkiewicz; Alexander Köwitsch; Nada Milosevic-Oljaca; Patrick Rider; Sven Rofall; Jörg Franke; Ole Jung; Ralf Smeets; Reinhard Schnettler; Sabine Wenisch; Mike Barbeck
Journal:  Int J Mol Sci       Date:  2018-03-12       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.